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Subtotal hysterectomy in modern gynecology: 
A decision analysis 
James R. Scott, MD, Howard T. Sharp, MD, Mark K. Dodson, MD, Peggy A. Norton, MD, and 
Homer R. Warner, MD 
Salt Lake City, Utah 
OBJECTIVE: Our purpose was to compare the risks and benefits of subtotal (supracervical) hysterectomy 
with those of total hysterectomy in women at low risk for cervical cancer. 
STUDY DESIGN: A decision analysis was performed. Baseline probabilities for operative and 
postoperative morbidity, mortality, and long-term quality of life were established for subtotal and total 
hysterectomy. 
RESULTS: Operative complication rates and ranges for total abdominal hysterectomy were infection 
3.0% (3.0% to 20.0%), hemorrhage 2.0% (2.0% to 15.4%)! and adjacent organ injury 1.0% (0.7% to 
2.0%). Those for subtotal hysterectomy were infection 1.4% (1.0% to 5.0%), hemorrhage 2.0% (0.7% to 
4.0%), and adjacent organ injury 0.7% (0.6% to 1.0%). Operative mortality, the risk for development of 
cervicovaginal cancer, and long-term adverse effects on sexual or vesicourethral function were low In 
both groups. 
CONCLUSIONS: Recently proposed benefits from subtotal hysterectomy are not well proven. Total 
hysterectomy remains the procedure of choice for most women. (Am J Obstet Gynecol 1997;176:1186-92.) 
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Total hysterectomy with removal of the cervix has been 
standard practice in the United States since the 1950s, 
when a 1% to 2% incidence of cervical stump carcinoma 
was reported. However, the lower risk for cervical cancer 
with modem screeni.ng tests has led to a recent resur-
gence of interest in subtotal hysterectomy (supracervical 
uterine amputation). Proponents contend that cervical 
conservation results in fewer intraoperative complica-
tions and fewer postoperative sexual and bladder prob-
lems.1·3 To date, there are no adequately controlled trials 
to examine these issues. Decision analysis is a method 
used to predict the potential results of different thera-
peutic options based on uncertain data. ·The purpose of 
this study was to usc a decision analysis technique to 
determine the advantages and disadvantages of subtotal 
hysterectomy compared with total hysterectomy. 
Material and methods 
Data sources. Probabilities for events were derived 
from a comprehensive literature review. The MEDLINE 
database was used to locate relevant articles published in 
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the English language between 1980 and 1996. Articles 
reporting results of original research were given priority, 
although review articles and commentaries were con-
sulted as well. Additional studies were located by review-
ing bibliographies of articles located by MEDLINE and 
consulting experts in the field. Three recent unpub-
lished cohort studies and one unpublished randomized 
trial were also evaluated. Studies were reviewed and 
classified with use of a modified U.S. Preventive Services 
Task Force system as follows4 : (l) properly designed 
randomized controlled trial, (2) controlled trial ·without 
randomization, cohort, or case-control study, and (3) all 
other sources, including descriptive studies and opinions 
of respected authorities based on clinical experience. 
The overall strength of the supporting evidence for 
each outcome variable was then graded as good (A), fair 
(B), or poor (C) on the basis of the quality and number 
of studies. These data were used to assess validity and to 
determine the most reasonable baseline probabilities. 
Decision model. We focused on subtotal versus total 
hysterectomy as treatment for benign uterine disease in 
women at low risk for cervical carcinoma. Excluded from 
the analysis were hysterectomies performed (1) as an 
emergency procedure or with anatomic distortion where 
surgical judgment dictates the need for subtotal hyster-
ectomy and (2) in women with previous abnormal Papa-
nicolaou smears, cervical intraepithelial neoplasia, hu-
man papillomavirtis infections, or other characteristics 
known to place them at higher risk for development of 
carcinoma. 
... 
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Fig. 1. Decision model. Square at far lefl, Choice between two treatment options: total hysterectomy or 
subtotal hysterectomy. Round nodes, Chance outcomes; end branches, final outcome states. 
A decision model was used to estimate sequelae from 
the two surgical procedures (Fig. 1). The basic choices 
were to perform subtotal hysterectomy or total hysterec-
tomy. With either operation, the following possible out-
comes were evaluated on the basis of the available 
literature: (1) a technically successful uncomplicated 
operation with no short- or long-term sequelae or (2) 
intraoperative or postoperative morbidity or mortality, 
including the development of invasive carcinoma of the 
cervix (subtotal) or vaginal cuff (total). 
Baseline complication rates were those most com-
monly reported from the most well-designed studies, and 
the ranges included all reported rates. Infection was 
defined as any serious operative site or wound infection 
needing treatment. Hemorrhage was intraoperative or 
postoperative blood loss > 1000 ml or that required 
blood transfusion. Adjacent organ injury referred to 
inadvertent bladder, ureteral, or bowel damage. Sexual 
dysfunction included dyspareunia and reduced coital 
frequency, libido, orgasmic frequency, and overall satis-
faction. Persistent vesicourethral symptoms were fre-
quency, nocturia, urgency, and incontinence. Other 
complications judged to have similar rates for both 
operations were not considered. These included throm-
boembolic disease, fascial dehiscence, paralytic ileus, and 
small bowel obstruction. 
The decision analysis was utility based. Quality of life 
after each of the two operative procedures was deter-
mined by estimating the level of disability avoided. 
Disability \vas defined as 100% with death and 0% in a 
healthy woman with no morbidity. The length of disabil-
ity assigned to each complication was an average agreed 
on by the authors from our experience with gynecologic 
surgical patients, and the percent disability was based on 
our estimate of patient perceptions. Life expectancy 
rates were obtained from the National Center for Health 
Statistics (Vital Statistics of the United States, 1992, Vol. 
II, Sec 6, Life Tables) .5 
The expected outcome from each of the two surgical 
procedures was estimated in terms of days of full func-
tionality (good days) lost as a result of the procedure and 
its complications. For example, the number of good days 
lost after total hysterectomy as a result of infection ( dl.i) 
was estimated by multiplying the probability or likeli-
hood of infection (p.i.) by the fraction of full function-
ality lost by the patient because of the postoperative infec-
tion (f.i) and by the duration of the infection in days ( d.i): 
dl.i = p.i X f.i X d.i. 
The expected number of days lost because of surgical 
death (dl.s) was the product of the surgical mortality rate 
(smr) and the life expectancy (le) of the patient minus 
the patient's age (a): 
dl.s = smr X (Ie - a) X 365 
Similar equations were used to represent the cost of each 
potential adverse effect of surgery, and the costs were 
then summed for each surgical procedure to provide a 
basis for comparison. 
Results 
Table I lists the perioperative and long-term compli-
cations considered, the probability that each complica-
tion would occur with either surgical procedure, and the 
quality and strength of evidence. The rates of infection, 
hemorrhage, and intraoperative injury were somewhat 
less with subtotal hysterectomy, but the risk of death 
from cervicovaginal cancer was essentially eliminated 
with total hysterectomy. The effect of the two procedures 
on sexual function was particularly difficult to interpret 
because of conflicting data and the potential for bias in 
most studies. There were no differences in other compli-
cations or mortality between the two groups. 
Because the importance of a specific complication 
varies . with patients, scenarios can be constructed by 
changing the percent disability as perceived by an indi-
vidual patient. In the following two examples, it was 
assumed that the hysterectomy was necessary on the basis 
of accepted indications and that yearly cervical cytologic 
examinations were normal preoperatively. 
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Table I. Probability of outcomes and quality of evidence used in decision model 
Probability Evidence 
Complication Baseline I &nge Quality l Strength References 
Total hysterectomy 
Surgical death 0.001 0.0005-0.006 II Good fi.-9 
Infection O.o3 0.03-0.20 l Good 10-12 
Hemorrhage 0.02 0.02-0.15 II Fair 10, 12 
Adjacent organ injury 0,01 0.007..0.02 ll Fair 6, 12, 13 
Impaired sexual response 0.0] 0.00-0.25 III Poor 3, 8, 14-18 
Vesicourethral symptoms 0,01 0.00..0.26 III Poor 7, 19-24 
Vaginal cancer death 0.00 0.00-< 0.0001 III Good 7, 25-27 
Subtotal hysterectomy 
Surgical death 0.001 0.0005..0.004 II Fair fi.-9 
Infection 0.014 0.01-0.05 II Fair 10, ll 
Hemorrhage 0.02 0.007-0.04 II Fair 10-12 
Adjacent organ injury 0.007 0.006..().01 II Fair 6, 12, 13 
Impaired sexual function 0.005 0.00-0.01 III Poor 3, 11, 14, 16, 17 
Vesicourethral symptoms 0.001 0.00-0.001 III Poor 7, 19-21 
CeiVical cancer death* 0.001 0.0003-0.03 Ill Good 7, 28, 29 
*A 67% cure rate was the percentage used to calculate potential lives saved by total hysterectomy compared with subtotal 
hysterectomy.30 
Table II. Hysterectomy decision 
Complications Disability(%) Probability Disability (days) Good days lost 
Total hysterectomy 
Surgical death 100 0.001 12,775 12.78 
Infection 20 0.03 5 0.03 
Hemorrhage 25 0.02 10 0.05 
Adjacent organ iqjury 50 0.01 120 0.60 
Impaired sexual response 5 0.01 12,775 5.39 
Vesicourethral symptoms 5 0.01 12,775 6.39 
Vaginal cancer death 100 0.00 9,175 0.00 
Cost in days lost of total 13.46 
hysterectomy 
Subtotal hysterectomy 
Surgical death 100 0.001 12,775 12.76 
Infection 20 0.01 5 0.01 
Hemorrhage 25 0.02 10 0.05 
Adjacent organ injury 50 0.007 120 0.42 
Impaired sexual response 5 0.005 12,775 9.19 
Vesicourethral symptoms 5 0.001 12,775 0.64 
CeiVica1 cancer death 100 O.Dl 9,175 91.75 
Cost in days lost of subtotal 96.06 
hysterectomy 
Conclusion 
Advantage: Total hysterectomy 83 (years 0.23) 
This patient, a 4&-year-old woman whose life expectancy of 80 years gives her 12,775 potential good days, has no preference between 
total or subtotal hysterectomy, but she wants to minimize the chance of ceiVical cancer. In this circumstance 83 quality days oflife would 
be gained by advising total hysterectomy. 
Table II represents the usual clinical situation favoring 
total hysterectomy derived from baseline probabilities 
and the estimated percent disability for each potential 
complication. 
Table HI illustrates how the decision process can be 
used to individualize treatment. In this case subtotal 
hysterectomy may be justified. 
Comment 
Evidence-based medicine is becoming prevalent in 
contemporary patient care. Treatment recommenda-
tions derived from experience, intuition, and traditional 
literature reviews have been criticized because they can 
be biased and misleading. Metaanalyses may provide 
more reliable information on the basis of systematic, 
replicable, and more objective methods. However, ran-
domized trials and properly controlled cohort studies, 
which are necessary for high-quality metaanalyses, are 
not available for most therapeutic decisions physicians 
must make. Decision analysis has long been used in 
business to predict outcomes on the basis of uncertain 
data. This systematic quantitative approach to assess the 
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Probability Disability (days) Good da;•s lost 
0.001 12,775 12.78 
0.03 5 0.03 
0.02 10 0.05 
0.01 120 0.60 
~.01 12,775 25.55 
0.01 12,775 6.39 
0.00 9,175 0.00 
45.40 
0.001 12,775 12.78 
O.ol 5 0.01 
0.02 10 0.05 
0.007 120 0.42 
0.005 12,775 12.78 
0.001 12,775 0.64 
0.001 9,175 9.18 
23.07 
22 (0.06 year) 
This patient, a 45-year-old woman, has read about and is particularly apprehensive about the possibility of future sexual dysfunction 
,,;,th total hysterectomy. Although most evidence indicates that postoperative sexual problems are uncommon, no amount of 
explanation or reassurance convinces her that removal of ceiVi.x would not be detrimental. A I% probability of decreased sexual 
satisfaction was assigned for total hysterectomy, and the patient's own estimate of 20% disability for that complication was used in the 
formula. Subtotal hysterectomy would potentially give her 22 extra quality days of life. In this case subtotal hysterectomy would be 
emotionally reassuring to the patient, and her long-term chance of ceiVi.cal neoplasia is acceptably low. 
relative value of different decision options has been 
proposed as a method to help clinicians manage individ-
ual patientsY 
Increased consumer and physician interest in subtotal 
hysterectomy reflects the recent trend toward more 
conservative pelvic surgical procedures such as myomec-
tomy and endometrial ablation. The popularity of lapa-
roscopic hysterectomy may also be a contributing factor 
because it is technically easier to leave the cervix. How-
ever, it is the responsibility of those who promote any 
new surgical procedure to prove that it is better than the 
one it is to replace.32 
We started with the premise that total hysterectomy 
remains the appropriate procedure for all women at risk 
for the later development of cervical neoplasia. There 
are substantial numbers of women in this category. 
Subtotal hysterectomy could only be considered for 
those with negative preoperative cervical cytologic results 
because invasive cervical carcinoma usually occurs in 
unscreened women or those with abnormal Papanico-
iaou smears. The contemporary lifetime risk of cervical 
cancer in a monogamous woman with at last three 
normal Papanicolaou smears is 0.05%, and the 5-year risk 
for development of cervical carcinoma is lowered by 69% 
with two to four previous negative smears.33 Among 1104 
women with unreported preoperative cytologic results 
who underwent subtotal hysterectomy for benign condi-
tions, two (0.2%) had cervical cancer during 10 years of 
observation .28 The risk of cervical carcinoma after subto-
tal hysterectomy might be further lowered by removing 
the endocervix or squamocolumnar junction.3· 29 
The primary reason advanced for subtotal hysterec-
tomy is to retain normal sexual function, but there are 
few convincing data to show that total hysterectomy is 
related to long-term sexual dysfunction . In the classic 
studies in the 1950s, Kolodny, Masters, and Johnson54 
documented that women may have uterine contractions 
associated with orgasm but that the cervix played no role 
in sexual function. In most recent studies claiming an 
advantage for subtotal hysterectomy, criteria used to 
evaluate sexual satisfaction are inconsistent, outcome 
values are not well defined, and one component some-
times worsens while another improves.3• 7· 11• 1"-17 The 
preponderance of evidence suggests that detrimental 
effects on sexual function are rare with either operation 
and preoperative sexual activity appears to be the most 
important factor in predicting postoperative sexual satis-
faction .16· 17 Overall, there are few differences in the rate 
of postoperative dyspareunia, coital frequency, or libido 
in patients with either operation. vVhether reduced or-
gasmic function occurs in a small percentage of women 
when the cervix is removed, as claimed by some, remains 
to be proved by adequately controlled studies. The data 
are equally uncertain regarding postoperative bladder 
symptoms, and they are inadequate to evaluate all .other 
proposed advantages of subtotal hysterectomy. 
There are few published data on adverse effects. of 
subtotal hysterectomy, but subsequent trachelectomy has 
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been necessary in some patients because of continued 
bleeding, intraepithelial neoplasia, or prolapse of the cer-
vical stump. An abdominal hysterectomy by laparoscopy or 
laparotomy is usually necessary to leave the cervix, but total 
vaginal hysterectomy is less expensive and is associated 
with fewer complications.55 Less frequent Papanicolaou 
smears are needed after total hysterectomies for benign 
disorders,26• 27 but women who have undergone subtotal 
hysterectomy require regular screening conforming to 
established guidelines for cervical cancer prevention. 
This would mean additional expenses for abnormal Papa-
nicolaou smears including repeat cytologic studies, colpos-
copy, and treatment such as cryotherapy or conization. 
It is apparent that the use of decision analyses in 
clinical medicine has limitations. Potential bias in obser-
vational studies make judgments about probabilities of 
clinical events imprecise and subjective. Moreover, satis-
faction with a specific outcome may be viewed differently 
by physicians and patients. Physicians often focus on 
treatment success or surgical complication rates, whereas 
convenience, expense, pain, and emotional concerns 
may be key issues for patients. Quality-of-life assessment 
includes changes in physical, functional, mental, and 
social health after surgery, but translating these compo-
nents into a quantitative value is a very complex task.36 
In summary, the alleged sexual and genitourinary 
benefits of subtotal hysterectomy over total hysterectomy 
are not proved, and well-designed prospective trials are 
needed to address these issues. The risk of cervical cancer is 
low in patients properly selected for subtotal hysterectomy, 
but total hysterectomy is better studied with longer 
follow-up, is less costly in the long term, and therefore 
remains the procedure of choice for most women. 
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Discussion 
DR. HARVEY T. HUDDLESTON, Shreveport, Louisiana. 
Decision analysis was reported in a direct application to 
medicine by Lindley in l 975. 1 It has been applied to the 
management of 13 disorders in medicine (e.g., appendi-
citis, elective cesarean section, bowel cancer, and ovarian 
cancer), but this study may be significant in that it seems 
to be the first application to benign gynecologic surgery. 
For many years total hysterectomy has been the proce-
dure of choice for women requiring removal of the 
uterus. Certainly a total hysterectomy should be used in 
any patients who are at risk for the development of 
cervical cancer, and the authors were quick to point this 
out. A subtotal hysterectomy may be a reasonable option 
in those monogamous women who have repeatedly had 
negative Papanicolaou smears. However, the alleged 
advantages of subtotal hysterectomy are based on "soft 
data" in most instances, which the authors of this study 
have been able to illustrate by their review of the 
literature and the use of a statistical technique called 
"decision analysis. n 
The assumptions that were made by the authors as to 
the quality of the controlled trials and the results of 
scientific papers that were studied rest predominantly on 
subjective perceptions by both the authors and the 
patients, rather than objective facts. As was pointed out at 
the outset by the authors, decision analysis has been used 
by business to predict outcomes on the basis of uncertain 
data. I believe that the operative words here are "uncertain 
data" As such, the use of decision analysis in medicine 
essentially relies on "soft data", rather tl1an ''hard data" to 
arrive atspecific recommendations for the clinician in his 
or her management of a patient. As illustrated in this 
study, this approach did not seem to be of value in 
resolving the question as to whether a total or subtotal 
hysterectomy had the advantage. Is there really no dif-
ference in the outcomes of total and subtotal hysterec-
tomy? The answer may be that decision analysis is a good 
tool to be used to augment clinical decisions, but when 
applied to retrospective studies of too poor evidence quality 
and strength it cannot discrin1inate between the two. 
It should always be borne in mind that the conclusions 
that are derived from a study are the reflection of the 
data from which they are derived. Decision analysis may 
not be the best statistical method by which to evaluate 
the relationship between surgery for total hysterectomy 
versus subtotal hysterectomy because (l) decision analy-
sis cannot overcome the flaws in individual studies, (2) it 
is weak when results from contradictory observational 
studies are combined, and (3) some epidemiologists 
argue that the technique should be reserved for data 
from randomized controlled studies. 
In summary, I congratulate the authors for having the 
courage to try decision analysis in an effort to better 
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tailor proposed surgery to the needs of the patient (make 
the surgery fit the patient, not the patient fit the sur-
gery). It seems that from this study that it was not 
effective in differentiating one procedure to have an 
advantage over the other. The final comments are per-
haps more appropriate and I believe correct: "It is 
apparent that the use of decision analysis in clinical 
studies has several limitations. Potential bias in observa-
tional studies makes judgments subjective. Moreover, 
• satisfaction with a specific surgical outcome may be 
viewed differently by physicians and patients." 
I have several questions. (1) In Table I "probabilities" 
are derived from fair to poor, evidence quality, which 
may or may not be applicable to your particular patient. 
Would you comment? (2) Also in Table I the "probabil-
ities" derived were from poor to fair evidence quality in 
six of seven parameters studied. Does this not seem to be 
relying too heavily on inferior evidence quality data to 
assist in a major clinical decision? (3) In Table II the 
"probability" for a vaginal cancer death is indicated as 0. 
The incidence of primary squamous cell cancer of the 
vagina is 1% to 2%. Several authors, Rutledge,2 Schiffer 
et a1.,3 Gallup and Morley,4 Jimerson and MerrilV Stuart 
et al.,6 and Bell et al.;' have reported series of squamous 
cell cancer of the vagina after hysterectomy for benign 
disease. If the probability of a vaginal cancer death is 0, 
can it be a complication of this surgery? If it is, and you 
didn't find any cases in your sample, then could it not 
mean that your sample is not sufficiently large? 
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DR. MARGUERITE K. SHEPARD, Indianapolis, Indiana. 
The concept of evidence-based medicine was first intro-
duced in 1992.1 Although representatives of several U.S. 
medical schools were included in the original working 
group, the predominant membership was Canadian, 
presumably an outgrowth of the Canadian program of 
national health care. Impetus toward this approach to 
medical decision making in the United States clearly is 
given by the trend toward managed care and the more 
cost-effective allocation of finite medical resources. In 
1993 Grin1es2 proposed the use of evidence-based med-
icine in obstetrics and gynecology. The examples he used 
in support of the evidence-based approach, including the 
routine use of episiotomy, repeat cesarean section, and 
11 92 Scott et al. 
Table I. Comparison of preliminary and final versions 
Complication Preliminary Final 
Total 
Infection 0.09 (0.05-D.20) 0.03 (0.03-0.20) 
Impaired sex 0.00 (0.00.0.20) 0.01 (0.00-0.25) 
Vesicourethro. 0.00 (0.00-0.26) 0.01 (0.00-0.26) 
Subtotal 
Surgical death 0.004 (0.0005-0.004) 0.001 (0.0005.{).004) 
Impaired sex 0.00 (0.00) 0.005 (0.00.0.01) 
electronic fetal monitoring, were all supported by a 
significant body of literature. 
Dr. Scott and colleagues have used the evidence-based 
approach to compare the advantages of subtotal hyster-
ectomy with those of total hysterectomy in appropriately 
selected patients. They have done an excellent job of 
culling the recent literature for appropriate supporting 
data. They have reviewed >30 reports to compare both 
procedures for five objective and two subjective potential 
sequelae. All reports have been evaluated for the quality 
and strength of the evidence. It becomes immediately 
obvious from the initial comparison seen in Table I that 
both the quality and strength of data are better for total 
hysterectomy and the objective sequelae, including sur-
gical death, infection, hemorrhage, adjacent organ in-
jury, and genital tract cancer death, than they are for 
subtotal hysterectomy and those sequelae that seem to 
mean the most to the patients requesting this procedure, 
that is, impaired sexual response and vesicourethral 
symptoms. This finding underscores one of the biggest 
problems with the evidence-based approach to many 
clinical problems with which we have to deal every day: 
the evidence available is inadequate in strength, quality, 
or amount to make a rational decision. Once again we must 
fall back on our clinical judgment. One obvious solution to 
this problem is to make a concerted effort. to collect some 
data in these areas of controversy. The concern over 
impaired sexual response is one of the main reasons that 
women are requesting subtotal hysterectomy. Many 
women, when asked, state that the topic was never discussed 
with them at all. Although still somewhat subjective, it 
would not be difficult to ask the patient and her parmer a 
few targeted questions such as, ''How important are uter-
ine contractions and tension on the uterosacral liga-
ments to your enjoyment of intercourse?" and "Are 
vaginal barrel tone and length significant components of 
your response and enjoyment?" and "Is it important to 
have the sensation that the penis is hitting something?" 
It would be even easier to collect more objective data 
in the area of vesicourethral symptoms. It would only take 
committing the time· and the money to performing tar-
geted preoperative and postoperative urodynamic studies. 
The difficulties with applying the evidence-based ap-
proach with inadequate supporting data are illustrated 
by the difficulties that the current authors have encoun-
tered. These are subtle but significant differences be-
tween the preliminary and final versions. In the first 
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version the condensation states "Elective subtotal hyster-
ectomy may be an acceptable alternative to total hyster-
ectomy in properly selected women," whereas in the 
second version the statement "Advantages and disadvan-
tages of subtotal versus total hysterectomy are presented" 
takes a pointedly neutral stance. The conclusion pre-
sented in the program states " . . . the contemporary risk 
of developing cervical cancer in women with normal 
cytology is minimal. Both subtotal and total hysterectomy 
• appear to be acceptable options for this group of worn- . 
en." However, the conclusion in the final version, 'Total 
hysterectomy remains the procedure of choice . for most 
women," is definitely in favor of total hysterectomy. 
Finally, a comparison of the tables between the prelimi-
nary and final versions is seen in Table I. As far as I could 
tell from comparing the two studies, essentially the same 
references were used to construct the two tables but the 
interpretation of the data differed. When the evidence-
based model is applied, the first version sets up three 
scenarios whereas the second version only uses one. 
I have . three questions. (1) How and why ·were the 
revised estimates of the probabilities of adverse occur-
rences made? (2) Why were the comparisons changed 
from three cases to one? (3) In the authors' opinion, how 
do sub de changes in interpretation of the data affect the 
process of decision analysis? 
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DR. SHARP (Closing). Let me start with the . question 
about whether we were relying on poor evidence for 
subtotal hysterectomy data, as both Dr. Huddleston and 
Dr. Shepard asked. The answer is yes. We really are left 
with whatever is available in the literature; unfortunately, 
the quality of literature is much better for total hysterec-
tomy. That is perhaps one weakness of the study, and we 
fully recognize that. 
One reason we did the decision analysis is that there 
are no good data for a metaanalysis. 
Dr. Huddleston also asked whether vaginal vault can-
cer really 0%; this is difficult because the probability of 
this is very low, there really were limited data available, 
and, in fact, in many cases all we had was a numerator · 
and not a denominator. So it was difficult, but it probably 
is very close to 0%. 
Dr. Shepard also asked about the preliminary versus 
the final article and how did we come up with our final 
percentages, etc. We had all the authors review the 
literature independently, and we our estimation as to the 
probability baseline. We didn't always agree, and we 
wrestled back and forth. We did eventually end up 
changing it to the final version after the consensus. 
